In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

Tomotsugu Ichikawa, Takashi Tamiya, Yoshiaki Adachi, Yasuhiro Ono, Kengo Matsumoto, Tomohisa Furuta, Yoko Yoshida, Hirofumi Hamada, Takashi Ohmoto

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

We evaluated the therapeutic efficacy and neurotoxicity of adenovirus- mediated transduction of the cytosine deaminase (CD) gene and 5- fluorocytosine (5-FC) for experimental malignant brain tumors. The 5-FC sensitivity in 9 L cells infected by an adenovirus vector expressing CD (AdexCACD) was increased 1700-fold compared with control cells. Rats bearing 9 L brain tumors were treated with an intratumoral injection of AdexCACD followed by intraperitoneal administration of 5-FC. The rats demonstrated remarkable inhibition of tumor growth by magnetic resonance imaging, and 7 of 10 rats survived for >90 days. To evaluate the potential side-effects of the 5-FC/CD gene therapy, rats were treated with an intracerebral injection of AdexCACD into the right basal ganglia and with 5-FC. The magnetic resonance imaging showed a highly enhanced area on the gadollinium-enhanced T1 - weighted image at 18 days postinjection. Pathologically, this corresponded to an area of necrosis with surrounding apoptotic cells. In addition, there was demyelination and gliosis with enlargement of the lateral ventricles. These results suggest that the 5-FC/CD gene therapy may provide an anticancer effect for malignant brain tumors in humans, but also show that there are neurotoxic effects on normal brain tissue.

Original languageEnglish
Pages (from-to)74-82
Number of pages9
JournalCancer Gene Therapy
Volume7
Issue number1
Publication statusPublished - 2000

Fingerprint

Cytosine Deaminase
Flucytosine
Adenoviridae
Glioma
Genetic Therapy
Brain Neoplasms
Magnetic Resonance Imaging
Injections
Gliosis
Lateral Ventricles
Demyelinating Diseases
Basal Ganglia
Necrosis
Brain
Growth
Genes

Keywords

  • Adenovirus vector
  • Malignant glioma
  • Neurotoxicity
  • Suicide gene therapy

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Ichikawa, T., Tamiya, T., Adachi, Y., Ono, Y., Matsumoto, K., Furuta, T., ... Ohmoto, T. (2000). In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Therapy, 7(1), 74-82.

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. / Ichikawa, Tomotsugu; Tamiya, Takashi; Adachi, Yoshiaki; Ono, Yasuhiro; Matsumoto, Kengo; Furuta, Tomohisa; Yoshida, Yoko; Hamada, Hirofumi; Ohmoto, Takashi.

In: Cancer Gene Therapy, Vol. 7, No. 1, 2000, p. 74-82.

Research output: Contribution to journalArticle

Ichikawa, T, Tamiya, T, Adachi, Y, Ono, Y, Matsumoto, K, Furuta, T, Yoshida, Y, Hamada, H & Ohmoto, T 2000, 'In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus', Cancer Gene Therapy, vol. 7, no. 1, pp. 74-82.
Ichikawa, Tomotsugu ; Tamiya, Takashi ; Adachi, Yoshiaki ; Ono, Yasuhiro ; Matsumoto, Kengo ; Furuta, Tomohisa ; Yoshida, Yoko ; Hamada, Hirofumi ; Ohmoto, Takashi. / In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. In: Cancer Gene Therapy. 2000 ; Vol. 7, No. 1. pp. 74-82.
@article{ffa78e969b994f9799327b4402070344,
title = "In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus",
abstract = "We evaluated the therapeutic efficacy and neurotoxicity of adenovirus- mediated transduction of the cytosine deaminase (CD) gene and 5- fluorocytosine (5-FC) for experimental malignant brain tumors. The 5-FC sensitivity in 9 L cells infected by an adenovirus vector expressing CD (AdexCACD) was increased 1700-fold compared with control cells. Rats bearing 9 L brain tumors were treated with an intratumoral injection of AdexCACD followed by intraperitoneal administration of 5-FC. The rats demonstrated remarkable inhibition of tumor growth by magnetic resonance imaging, and 7 of 10 rats survived for >90 days. To evaluate the potential side-effects of the 5-FC/CD gene therapy, rats were treated with an intracerebral injection of AdexCACD into the right basal ganglia and with 5-FC. The magnetic resonance imaging showed a highly enhanced area on the gadollinium-enhanced T1 - weighted image at 18 days postinjection. Pathologically, this corresponded to an area of necrosis with surrounding apoptotic cells. In addition, there was demyelination and gliosis with enlargement of the lateral ventricles. These results suggest that the 5-FC/CD gene therapy may provide an anticancer effect for malignant brain tumors in humans, but also show that there are neurotoxic effects on normal brain tissue.",
keywords = "Adenovirus vector, Malignant glioma, Neurotoxicity, Suicide gene therapy",
author = "Tomotsugu Ichikawa and Takashi Tamiya and Yoshiaki Adachi and Yasuhiro Ono and Kengo Matsumoto and Tomohisa Furuta and Yoko Yoshida and Hirofumi Hamada and Takashi Ohmoto",
year = "2000",
language = "English",
volume = "7",
pages = "74--82",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

AU - Ichikawa, Tomotsugu

AU - Tamiya, Takashi

AU - Adachi, Yoshiaki

AU - Ono, Yasuhiro

AU - Matsumoto, Kengo

AU - Furuta, Tomohisa

AU - Yoshida, Yoko

AU - Hamada, Hirofumi

AU - Ohmoto, Takashi

PY - 2000

Y1 - 2000

N2 - We evaluated the therapeutic efficacy and neurotoxicity of adenovirus- mediated transduction of the cytosine deaminase (CD) gene and 5- fluorocytosine (5-FC) for experimental malignant brain tumors. The 5-FC sensitivity in 9 L cells infected by an adenovirus vector expressing CD (AdexCACD) was increased 1700-fold compared with control cells. Rats bearing 9 L brain tumors were treated with an intratumoral injection of AdexCACD followed by intraperitoneal administration of 5-FC. The rats demonstrated remarkable inhibition of tumor growth by magnetic resonance imaging, and 7 of 10 rats survived for >90 days. To evaluate the potential side-effects of the 5-FC/CD gene therapy, rats were treated with an intracerebral injection of AdexCACD into the right basal ganglia and with 5-FC. The magnetic resonance imaging showed a highly enhanced area on the gadollinium-enhanced T1 - weighted image at 18 days postinjection. Pathologically, this corresponded to an area of necrosis with surrounding apoptotic cells. In addition, there was demyelination and gliosis with enlargement of the lateral ventricles. These results suggest that the 5-FC/CD gene therapy may provide an anticancer effect for malignant brain tumors in humans, but also show that there are neurotoxic effects on normal brain tissue.

AB - We evaluated the therapeutic efficacy and neurotoxicity of adenovirus- mediated transduction of the cytosine deaminase (CD) gene and 5- fluorocytosine (5-FC) for experimental malignant brain tumors. The 5-FC sensitivity in 9 L cells infected by an adenovirus vector expressing CD (AdexCACD) was increased 1700-fold compared with control cells. Rats bearing 9 L brain tumors were treated with an intratumoral injection of AdexCACD followed by intraperitoneal administration of 5-FC. The rats demonstrated remarkable inhibition of tumor growth by magnetic resonance imaging, and 7 of 10 rats survived for >90 days. To evaluate the potential side-effects of the 5-FC/CD gene therapy, rats were treated with an intracerebral injection of AdexCACD into the right basal ganglia and with 5-FC. The magnetic resonance imaging showed a highly enhanced area on the gadollinium-enhanced T1 - weighted image at 18 days postinjection. Pathologically, this corresponded to an area of necrosis with surrounding apoptotic cells. In addition, there was demyelination and gliosis with enlargement of the lateral ventricles. These results suggest that the 5-FC/CD gene therapy may provide an anticancer effect for malignant brain tumors in humans, but also show that there are neurotoxic effects on normal brain tissue.

KW - Adenovirus vector

KW - Malignant glioma

KW - Neurotoxicity

KW - Suicide gene therapy

UR - http://www.scopus.com/inward/record.url?scp=0033961839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033961839&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 74

EP - 82

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 1

ER -